157 related articles for article (PubMed ID: 11886000)
1. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer--a necessary risk?
Harvey ML; Geldart TR; Duell R; Mead GM; Tung K
Ann Oncol; 2002 Feb; 13(2):237-42. PubMed ID: 11886000
[TBL] [Abstract][Full Text] [Related]
2. No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer.
De La Pena H; Sharma A; Glicksman C; Joseph J; Subesinghe M; Traill Z; Verrill C; Sullivan M; Redgwell J; Bataillard E; Pintus E; Dallas N; Gogbashian A; Tuthill M; Protheroe A; Hall M
Eur J Cancer; 2017 Oct; 84():354-359. PubMed ID: 28866371
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.
Francis R; Bower M; Brunström G; Holden L; Newlands ES; Rustin GJ; Seckl MJ
Eur J Cancer; 2000 Oct; 36(15):1925-32. PubMed ID: 11000572
[TBL] [Abstract][Full Text] [Related]
4. 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
Huddart RA; O'Doherty MJ; Padhani A; Rustin GJ; Mead GM; Joffe JK; Vasey P; Harland SJ; Logue J; Daugaard G; Hain SF; Kirk SJ; MacKewn JE; Stenning SP;
J Clin Oncol; 2007 Jul; 25(21):3090-5. PubMed ID: 17634488
[TBL] [Abstract][Full Text] [Related]
5. The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patients.
Bhala N; Coleman JM; Radstone CR; Horsman JM; George J; Hancock BW; Hatton MQ; Coleman RE
Clin Oncol (R Coll Radiol); 2004 Feb; 16(1):40-7. PubMed ID: 14768754
[TBL] [Abstract][Full Text] [Related]
6. The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
Spermon JR; De Geus-Oei LF; Kiemeney LA; Witjes JA; Oyen WJ
BJU Int; 2002 Apr; 89(6):549-56. PubMed ID: 11942962
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of patients with testicular germ cell cancer.
Hartmann JT; Kanz L; Bokemeyer C
Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
[TBL] [Abstract][Full Text] [Related]
8. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
9. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Guney S; Guney N; Sonmez NC; Ergenekon E
Med Oncol; 2009; 26(2):136-42. PubMed ID: 18821067
[TBL] [Abstract][Full Text] [Related]
11. Imaging of the thorax in the management of germ cell testicular tumours.
White PM; Adamson DJ; Howard GC; Wright AR
Clin Radiol; 1999 Apr; 54(4):207-11. PubMed ID: 10210337
[TBL] [Abstract][Full Text] [Related]
12. Testicular cancer.
Nichols CR
Curr Probl Cancer; 1998; 22(4):187-274. PubMed ID: 9743088
[TBL] [Abstract][Full Text] [Related]
13. Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours.
Chung P; O'Malley ME; Jewett MAS; Bedard PL; Panzarella T; Sturgeon J; Moore MJ; Hamilton R; Hansen AR; Anson-Cartwright L; Gospodarowicz M; Warde P
Eur Urol Oncol; 2019 Jul; 2(4):437-442. PubMed ID: 31277780
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of clinical stage I testicular cancer patients: cost and risk benefit considerations.
Kakehi Y; Kamoto T; Kawakita M; Ogawa O
Int J Urol; 2002 Mar; 9(3):154-60; discussion 160-1. PubMed ID: 12010325
[TBL] [Abstract][Full Text] [Related]
15. [Management of non-seminomatous germ cell tumors of the testes].
Kawai K; Akaza H
Gan To Kagaku Ryoho; 2000 Apr; 27(4):522-9. PubMed ID: 10790993
[TBL] [Abstract][Full Text] [Related]
16. [Testicular germ cell tumors: prognosis].
Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M
Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
Bokemeyer C; Köhrmann O; Tischler J; Weissbach L; Räth U; Haupt A; Schöffski P; Harstrick A; Schmoll HJ
Ann Oncol; 1996 Dec; 7(10):1015-21. PubMed ID: 9037359
[TBL] [Abstract][Full Text] [Related]
18. Routine chest X-rays have no additional value in the detection of relapse during routine follow-up of patients treated with chemotherapy for disseminated non-seminomatous testicular cancer.
Gietema JA; Meinardi MT; Sleijfer DT; Hoekstra HJ; van der Graaf WT
Ann Oncol; 2002 Oct; 13(10):1616-20. PubMed ID: 12377651
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group.
Rustin GJ; Mead GM; Stenning SP; Vasey PA; Aass N; Huddart RA; Sokal MP; Joffe JK; Harland SJ; Kirk SJ;
J Clin Oncol; 2007 Apr; 25(11):1310-5. PubMed ID: 17416851
[TBL] [Abstract][Full Text] [Related]
20. Treatment in germ cell tumours: state of the art.
Tjan-Heijnen VC; Oosterhof GO; de Wit R; De Mulder PH
Eur J Surg Oncol; 1997 Apr; 23(2):110-7. PubMed ID: 9158183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
